Top Markets
Coin of the day
Delta-Fly Pharma, Inc. Delta-Fly Pharma, Inc.

Delta-Fly Pharma, Inc.

4598
Classificação em ações #32530
Delta-Fly Pharma, Inc., established in Tokushima, Japan, in 2010, is a... Delta-Fly Pharma, Inc., established in Tokushima, Japan, in 2010, is a biotechnology company focused on the development of innovative oncology drugs. Their comprehensive pipeline includes several drug candidates targeting various cancers. DFP-10917 is currently undergoing Phase III clinical evaluation in the United States and Phase I in Japan for relapsed/refractory acute myeloid leukemia. Another significant compound, DFP-14323, is in Phase III trials for lung cancer. The firm is also advancing DFP-17729 through Phase I/II studies for solid tumors. Furthermore, DFP-11207 has successfully completed its Phase I clinical trial for pancreatic cancer. For hematologic malignancies, DFP-14927 is in Phase I, while DFP-10825 is in preclinical development, targeting gastric and ovarian cancers.
Preço da ação
$0.69158324
Valor de mercado
$9.84M
Variação (1 dia)
0.00%
Variação (1 ano)
-84.15%
País
JP
Negociar Delta-Fly Pharma, Inc. (4598)

Categoria

Histórico de preços das ações de Delta-Fly Pharma, Inc. (4598)
Preço de fecho mais alto: $0.69 em 2026-08-01

Preço de fecho mais baixo: $3.99 em 2024-07-01
Histórico de preços das ações da Delta-Fly Pharma, Inc. de 2024 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2026 (TTM) -37.60%
2025 -13.51%
2024 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
$515.58 31.26%
US
$992.01 51.72%
NL
$736.64 7.19%
CH
$1.07K -6.40%
KR
$255.50 13.38%
BE